These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 37513554)

  • 21. Polymeric nanomicelles of curcumin: Potential applications in cancer.
    Farhoudi L; Kesharwani P; Majeed M; Johnston TP; Sahebkar A
    Int J Pharm; 2022 Apr; 617():121622. PubMed ID: 35227805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can Compounds of Natural Origin Be Important in Chemoprevention? Anticancer Properties of Quercetin, Resveratrol, and Curcumin-A Comprehensive Review.
    Cecerska-Heryć E; Wiśniewska Z; Serwin N; Polikowska A; Goszka M; Engwert W; Michałów J; Pękała M; Budkowska M; Michalczyk A; Dołęgowska B
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets.
    Aras A; Khokhar AR; Qureshi MZ; Silva MF; Sobczak-Kupiec A; Pineda EA; Hechenleitner AA; Farooqi AA
    Asian Pac J Cancer Prev; 2014; 15(9):3865-71. PubMed ID: 24935565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin penetration behavior of lipid-core nanocapsules for simultaneous delivery of resveratrol and curcumin.
    Friedrich RB; Kann B; Coradini K; Offerhaus HL; Beck RC; Windbergs M
    Eur J Pharm Sci; 2015 Oct; 78():204-13. PubMed ID: 26215463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of polyphenols in overcoming cancer drug resistance: a comprehensive review.
    Maleki Dana P; Sadoughi F; Asemi Z; Yousefi B
    Cell Mol Biol Lett; 2022 Jan; 27(1):1. PubMed ID: 34979906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticle formulations to enhance tumor targeting of poorly soluble polyphenols with potential anticancer properties.
    Bonferoni MC; Rossi S; Sandri G; Ferrari F
    Semin Cancer Biol; 2017 Oct; 46():205-214. PubMed ID: 28673607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural Product-Based Hybrids as Potential Candidates for the Treatment of Cancer: Focus on Curcumin and Resveratrol.
    Micale N; Molonia MS; Citarella A; Cimino F; Saija A; Cristani M; Speciale A
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer.
    Zhang L; Chen W; Tu G; Chen X; Lu Y; Wu L; Zheng D
    Int J Nanomedicine; 2020; 15():4417-4429. PubMed ID: 32606686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoformulations of Nutraceuticals for Cancer Treatment.
    Illahi AF; Muhammad F; Akhtar B
    Crit Rev Eukaryot Gene Expr; 2019; 29(5):449-460. PubMed ID: 32422001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Potential of Polyphenols-Loaded Polymeric Nanoparticles in Cardiovascular System.
    Pechanova O; Dayar E; Cebova M
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32707934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells.
    Catania A; Barrajón-Catalán E; Nicolosi S; Cicirata F; Micol V
    Breast Cancer Res Treat; 2013 Aug; 141(1):55-65. PubMed ID: 23959397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
    Li H; Krstin S; Wink M
    Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactoferrin-Based Ternary Composite Nanoparticles with Enhanced Dispersibility and Stability for Curcumin Delivery.
    Li X; He Y; Zhang S; Gu Q; McClements DJ; Chen S; Liu X; Liu F
    ACS Appl Mater Interfaces; 2023 Apr; 15(14):18166-18181. PubMed ID: 36893425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanotechnology-applied curcumin for different diseases therapy.
    Ghalandarlaki N; Alizadeh AM; Ashkani-Esfahani S
    Biomed Res Int; 2014; 2014():394264. PubMed ID: 24995293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progress in nanotechnology-based drug carriers for resveratrol delivery.
    Li C; Wang Z; Lei H; Zhang D
    Drug Deliv; 2023 Dec; 30(1):2174206. PubMed ID: 36852655
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Zhou H; Zheng B; McClements DJ
    J Agric Food Chem; 2021 Mar; 69(11):3340-3350. PubMed ID: 33689331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-administration of curcumin with other phytochemicals improves anticancer activity by regulating multiple molecular targets.
    Ghobadi N; Asoodeh A
    Phytother Res; 2023 Apr; 37(4):1688-1702. PubMed ID: 36883534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers.
    Thipe VC; Panjtan Amiri K; Bloebaum P; Raphael Karikachery A; Khoobchandani M; Katti KK; Jurisson SS; Katti KV
    Int J Nanomedicine; 2019; 14():4413-4428. PubMed ID: 31417252
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment.
    Fantini M; Benvenuto M; Masuelli L; Frajese GV; Tresoldi I; Modesti A; Bei R
    Int J Mol Sci; 2015 Apr; 16(5):9236-82. PubMed ID: 25918934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics.
    Patra S; Pradhan B; Nayak R; Behera C; Rout L; Jena M; Efferth T; Bhutia SK
    Semin Cancer Biol; 2021 Aug; 73():310-320. PubMed ID: 33152486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.